Joincare Medical Expands Strategically Amid Governance Reforms
Jointek China accelerates its strategic layout in early 2026 by establishing five subsidiaries, focusing on medical devices and biotechnology. Simultaneously, the company is upgrading its governance, issuing science and technology innovation bonds, and participating in the restructuring of *ST Meigu, demonstrating a clear diversified development strategy. These initiatives aim to optimize the profit structure, enhance overall competitiveness, and lay a solid foundation for future development.









